Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison
- 31 January 2008
- Vol. 17 (1) , 19-26
- https://doi.org/10.1016/j.seizure.2007.05.019
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Evidence‐based Treatment of Idiopathic Generalized Epilepsies with New Antiepileptic DrugsEpilepsia, 2005
- Efficacy of Levetiracetam: A Review of Three Pivotal Clinical TrialsEpilepsia, 2001
- Efficacy and Tolerability of Levetiracetam 3000 mg/d in Patients with Refractory Partial Seizures: A Multicenter, Double‐Blind, Responder‐Selected Study Evaluating MonotherapyEpilepsia, 2000
- Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial SeizuresEpilepsia, 2000
- Levetiracetam for partial seizuresNeurology, 2000
- Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsyEpilepsy Research, 1996
- Double‐Blind, Placebo‐Controlled Trial of Topiramate (600 mg Daily) for the Treatment of Refractory Partial EpilepsyEpilepsia, 1996
- Double‐Blind, Placebo‐Controlled Trial of Topiramate as Add‐on Therapy in Patients with Refractory Partial SeizuresEpilepsia, 1996
- Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosagesNeurology, 1996
- Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosagesNeurology, 1996